OR WAIT 15 SECS
© 2021 MJH Life Sciences and Dermatology Times and Multimedia Medical, LLC. All rights reserved.
© 2021 MJH Life Sciences™ , Dermatology Times and Multimedia Medical, LLC. All rights reserved.
January 18, 2021
This week’s edition of The Mainstream Patient features stories on the benefits of lactic acid, itchy skin during the winter, tretinoin, 2021’s biggest beauty trend, plus more.
January 15, 2021
January 14, 2021
Learn more about what treatments are on the rise for plaque psoriasis, the latest management advice and what trends are shaping the future of the disease.
Click here to answer our weekly poll.
A glimpse at what to expect from Dermatology Times this week.
ICYMI, some of the content featured this week includes a new podcast episode and stories on finasteride, telehealth, medical device company acquisitions, updates in acne research, plus more.
Acne research delineating molecular and cellular pathogenic pathways gives insight into new therapeutic targets. According to a recent review, biologics and other therapies that modulate scar formation and wound healing will have value for treating severe acne.
Esther Freeman, MD, PhD, details how her and her fellow colleagues banded together to create a COVID-19 dermatology registry in just eight days. The registry has since seen over 1,000 submissions from frontline clinicians located in 40 countries, helping to identify and diagnose active COVID-19 through submitted skin findings.
January 13, 2021
Allergan Aesthetics has entered into a warrant agreement that will give the company an option to acquire Cypris Medical following the completion of a clinical trial evaluating Cypris’ Xact device.
Topicals and oral antibiotics, as well as research on the skin microbiome, are paving the way for the future of acne treatment, according to a recent presentation at the 2020 ODAC Pre-Conference Inflammatory Diseases Symposium.
January 12, 2021
A retrospective study shows significant differences in the characteristics of patients seen by telehealth during the COVID-19 pandemic versus those seen during in-office visits 1 year earlier.
A recent study shows an association between finasteride use and psychological adverse events (AEs) including suicidality. Dermatologists should weigh benefits and risks carefully when considering finasteride for certain patients with hair loss, according to one expert.